Boyi Gan

UT MD Anderson Cancer Center

NIH Rank #5239
  • Program Leader
  • R01 Holder
  • Early Career

NIH Funding · FY2024

Total Funding
$2M
Fiscal year 2024
Grants Awarded
6
Active NIH grants
National Rank
#5,239
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $2M across 6 grants · National rank #5239.

Top grants by award amount

Boyi Gan's NIH grant portfolio, ranked by award amount.

  • 5R01CA269646-02R01
    Targeting ferroptosis in cancer therapy
    $469.3K
    award amount
  • 5R01CA244144-05R01
    Targeting SLC7A11-induced nutrient dependency in cancer: mechanisms and preclinical translation
    $404.6K
    award amount
  • 5R01CA247992-04R01
    Targeting ferroptosis in radioresistance in lung cancer: mechanisms and preclinical translation
    $373.6K
    award amount
  • 5R01CA181196-11R01
    Studying metabolic stress signaling in renal cancer
    $329K
    award amount
  • 5U54CA274220-03U54
    Acquired Resistance to Therapy and Iron (ARTI) Center
    $263.5K
    award amount
  • 3U54CA274220-03S1U54
    Administrative Supplement: Investigating the role of iron redox dynamics in radiation resistance in esophageal cancer
    $177.1K
    award amount

Affiliation

Institutions that have administered grants for Boyi Gan.

Affiliated with UT MD Anderson Cancer Center (TX).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    UT MD Anderson Cancer Center
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #5239